Fennec Pharmaceuticals Inc (FENC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $410.25M
Last updated: Nov 17, 2026 at 4:42 PM ET
Fennec Pharmaceuticals Inc (FENC) Stock Chart
Fennec Pharmaceuticals (FENC) has a latest price of $13.58 on Nov 17, 2026. Its price rose 72.8% over the past 12 months. The month-end price rose 409.5% over the 10 years through Oct 2026, a compound annual rate of 17.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $12.50 in Apr 2018 and its lowest $1.74 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart FENC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for FENC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 14.4%, and over 6 months it rose 39.1%. The month-end price rose 48.8% over the 3 years through Oct 2026, a compound annual rate of 14.2%.
| Period | Change |
|---|---|
| 1 month | +32.2% |
| 3 months | +14.4% |
| 6 months | +39.1% |
| 12 months | +72.8% |
| 12 months, with dividends | +72.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +48.8% | +14.2% |
| 5 years | +10.6% | +2.0% |
| 10 years | +409.5% | +17.7% |
Price by Year
Its best calendar year was 2017, when the price rose 368.6%, and its weakest was 2024, when it fell 43.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.24 | +33.0% |
| 2025 | $7.70 | +21.8% |
| 2024 | $6.32 | -43.7% |
| 2023 | $11.22 | +16.9% |
| 2022 | $9.60 | +118.2% |
| 2021 | $4.40 | -40.9% |
| 2020 | $7.45 | +14.8% |
| 2019 | $6.49 | +1.7% |
| 2018 | $6.38 | -36.3% |
| 2017 | $10.02 | +368.6% |
Trading Range
The price is 27.2% above its 50-day average of $10.67 and 44.4% above its 200-day average of $9.41.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $13.58 | |
| 50-day average | $10.67 | +27.2% |
| 200-day average | $9.41 | +44.4% |
Price Risk
Over 3 years, its largest fall from a peak was 65.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.41 |
| Largest fall, 1 year | -35.8% |
| Largest fall, 3 years | -65.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About FENC
What is FENC's 1-year price change?
Fennec Pharmaceuticals's price rose 72.8% over the past 12 months. With dividends included, the 12-month total return was 72.8%.
What is FENC's 5-year price change?
Fennec Pharmaceuticals's month-end price rose 10.6% over the 5 years through Oct 2026, a compound annual rate of 2.0%. These figures leave out dividends.
What is FENC's beta?
Fennec Pharmaceuticals's 1-year beta against the S&P 500 is 1.41, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 35.8%.
Is the FENC chart free?
Yes. Advanced Charting for FENC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
FENC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors